Published
4 years agoon
A biotech company says its experimental drug has proved effective against the new coronavirus in a major U.S. government study that put it to a strict test.
Gilead Sciences’s remdesivir would be the first treatment to pass such a test against the virus, which has killed more than 218,000 people since it emerged late last year. Having a treatment could have a profound effect on the global pandemic, especially because health officials say any vaccine is likely a year or more away.
In this March 2020 photo provided by Gilead Sciences, rubber stoppers are placed onto filled vials of the investigational drug remdesivir at a Gilead manufacturing site in the United States. Given through an IV, the medication is designed to interfere with an enzyme that reproduces viral genetic material. (Gilead Sciences via AP)
The study, run by the National Institutes of Health, tested remdesivir versus usual care in about 800 hospitalized coronavirus patients around the world. The main result is how long it takes patients to recover.
Gilead gave no details on results Wednesday, but said an announcement is expected soon. NIH officials did not immediately reply to a request for comment.
Remdesivir is given through an IV and is designed to interfere with an enzyme that reproduces viral genetic material. In animal tests against SARS and MERS, diseases caused by similar coronaviruses, the drug helped prevent infection and reduced the severity of symptoms when given early enough in the course of illness. But it is not yet approved anywhere in the world for any use.
Fresno Pacific Classes Back Online Because of Omicron Surge
Fresno, Kern Residents Win $50K Each in Vaccination Lottery
The Latest: Germany Reports 24,000 Daily Coronavirus Cases
‘Tip of the Iceberg’ : More Dangerous Virus Variant Confirmed in 3 Fresno County Patients.
Local Schools Leader Says New COVID 3-Foot Desk Rule is ‘Game Changer’
Opinion: Legislative Staff Right to Unionize: What Could Go Wrong?